Helius joins BCI landscape with new subsidiary
The business, called Revelation Neuro, will be a wholly owned private subsidiary focused on developing non-implantable versions of BCIs.
Shares in the Nasdaq-listed company opened unchanged following the announcement.
Helius Medical develops its own portable neuromodulation stimulator platform to help with movement and balance. The US company stated it will combine newly developed intellectual property (IP) with existing technology – the latter will be licensed to Revelation Neuro.
While it has amassed over $70m in funding to date, Helius does not plan to pump additional capital into the subsidiary, instead opting to rely on financing through third-party sources.
BCIs are chips implanted in brain tissue that take brain signals and translate them into commands. The measured signals, which can be described as 'thoughts', are relayed to a secondary, external device which then carries out a specific function.
Through Revelation Neuro, Helius is opting to go down the non-implantable route. Whilst it did not reveal specifics of its planned BCI technology, a clue can be found in Helius' neuromodulation platform that uses the stimulation on the tongue to elicit brain activity. This method of modulation is known as translingual stimulation and does not require implantation.
Helius' CEO Dane Andreeff said: 'We believe Revelation Neuro's BCI technology will be a unique and less invasive therapeutic option.'
Revelation Neuro will also apply artificial intelligence (AI) to optimise response to the translingual stimulation, using datasets from Helius' experience in the movement dysfunction field. The algorithms will enable a precise and personalised approach to motor function rehabilitation.
'BCI-enabled improvement in functional rehabilitation is the initial focus of Revelation Neuro's efforts, with the potential in the future to address neurological conditions including cognitive deficit, mood and behaviour disorders,' Andreeff added.
The BCI landscape has received plenty of public attention, primarily in part due to Elon Musk-owned Neuralink. The company has implanted two paralysed patients with its chips, helping them play video games and chess, amongst other activities. Other companies like Synchron, BrainGate, and Clinatec, are more advanced in their clinical journey but it is hard to predict when the first BCIs will reach market, although some experts reckon approvals will be seen within the decade.
The US Food and Drug Administration (FDA) has already singled BCIs out due to their unique nature, issuing guidance in 2021 on their research and development. The agency shared its thoughts on a range of topics to help guide companies that are clinically testing devices but has so far remained tight-lipped on regulatory stipulates.
"Helius joins BCI landscape with new subsidiary" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
34 minutes ago
Asian shares mostly gain as eyes turn to meetings at the White House and Jackson Hole
BANGKOK -- Asian shares were mostly higher Monday after the S&P 500 and Nasdaq composite edged back from their record levels while the Dow inched to a new record close. U.S. futures were little changed as investors watched for developments in the Ukraine crisis following a summit between President Donald Trump and Russian President Vladimir Putin that brought no breakthroughs. Japan's Nikkei 225 gained 0.8% to 43.714.31, while the Hang Seng in Hong Kong added 0.1% to 25,291.42. The Shanghai Composite index jumped 1% to 3,732.44. Australia's S&P/ASX 200 picked up 0.2% to 8,959.30. The Kospi in South Korea declined 1.5% to 3,177.28 on heavy selling of semiconductor makers like Samsung Electronics, whose shares fell 2.2%. SK Hynix lost 3.3% as investors fretted over the possibility of more U.S. tariffs on computer chips. Trump was preparing to meet later Monday with Ukrainian President Volodymyr Zelenskyy and other European leaders in Washington. The European vanguard were not included in Trump's summit with Russian President Vladimir Putin last Friday. They are seeking to present a united front in safeguarding Ukraine and the continent from any widening aggression from Moscow. An annual meeting in Jackson Hole, Wyoming, of top central bankers later this week will be watched closely for hints about possible interest rate cuts from Federal Reserve chair Jerome Powell. He is due to speak Friday at the economic policy conference. 'While the official theme is labor markets, investors will scrutinize any hint of September policy direction, especially after last week's mixed inflation data,' Ipek Ozkardeskaya of Swissquote said in a commentary, adding that 'any progress on Ukraine peace talks could push global equities higher still.' Expectations have been building that the Fed will cut interest rates at its next meeting in September, though mixed reports on the U.S. economy have undercut those bets somewhat. One report Friday said shoppers boosted their spending at U.S. retailers last month, while another said manufacturing in New York state unexpectedly grew. A third said industrial production across the country shrank last month, when economists were looking for modest growth. Yet another report suggested sentiment among U.S. consumers is worsening because of worries about inflation, when economists expected to see a slight improvement. On Wall Street, UnitedHealth Group jumped 12% on Friday after famed investor Warren Buffett's Berkshire Hathaway said it bought nearly 5 million shares of the insurer during the spring, valued at $1.57 billion. Buffett is known for trying to buy good stocks at affordable prices, and UnitedHealth's halved for the year by the end of July because of a run of struggles. Berkshire Hathaway's own stock slipped 0.4%. Applied Materials helped lead Wall Street lower with a decline of 14.1% even though it reported better results for the latest quarter than analysts expected. The focus was on the company's forecast for a drop in revenue during the current quarter. Its products help manufacture semiconductors and advanced displays, and CEO Gary Dickerson pointed to a 'dynamic macroeconomic and policy environment, which is creating increased uncertainty and lower visibility in the near term, including for our China business.' Sandisk fell 4.6% despite reporting a profit for the latest quarter that blew past analysts' expectations. Investors focused instead on the data storage company's forecast for profit in the current quarter, which came up short of Wall Street's. On Friday, the S&P 500 fell 0.3%. The Dow Jones Industrial Average edged 0.1% higher. The Nasdaq composite sank 0.4%. In other dealings early Monday, U.S. benchmark crude oil rose 24 cents to $63.04 per barrel, while Brent crude, the international standard, climbed 16 cents to $66.01 per barrel.
USA Today
an hour ago
- USA Today
Liberals play partisan games with economic news
Will Democrats put politics aside and applaud as the American economy shows a strength and resilience that so many of them doubted? Probably not. Thanks to President Donald Trump's bold policies, it appears that the United States will avoid a recession this year − one that so many liberals were predicting only months ago. Will Democrats put politics aside and applaud as the American economy shows a strength and resilience that so many of them doubted? Probably not. The Bureau of Economic Analysis on July 30 released more good news about our nation's vibrant economy. Gross domestic product grew a healthy annual rate of 3% in the second quarter after recording a less than 1% decline in the first three months of this year. Fears of a recession should now dissipate like morning haze after the sunrise. Nearly all markers of a strong economy are in top form. Unemployment is low, hovering at 4.1%. The past three months have seen steady job growth. Average hourly earnings for U.S. workers grew 3.7% over the 12 months ending in June. Consumer spending is expected to rise, and there's been a modest uptick in consumer confidence. The Consumer Price Index, which measures inflation, increased 2.7% over the 12 months ending in June, far below the 40-year high recorded in President Joe Biden's term. Even the average price of eggs has dropped dramatically, to $3.31 per dozen, down from a spike to $8 in February and back to roughly the same price level as a year ago. Stock indexes continue to grow at a strong pace, recovering from the sell-off this spring driven by concerns over Trump's tariffs. The Nasdaq and S&P 500 have set multiple record highs in July, a boon to millions of Americans with retirement accounts and other investors. On the tariff front, Trump's new trade deal with the European Union should be a catalyst for further economic growth, particularly in the energy and construction sectors. If this is what a recession looks like, let's keep it coming. Critics said Trump was destroying the economy Despite such healthy economic markers, I doubt I'll see many kudos offered to the Trump administration for powering past a recession, which the left predicted in doomsday terms. Nobel Prize-winning economist Paul Krugman wrote in May that Trump and "MAGAnomics" were "destroying the economy and waging war on the middle class and the poor." The headline thundered that Trump was "making America backward again." Opinion: Trump's EU trade deal ushers in a golden age for blue-collar workers Interestingly, Krugman claimed that the U.S. economy was in good overall shape when Biden left office in January. He charged Trump with wrecking the economy in a mere three months. Now, that the data clearly shows otherwise, will Krugman admit his errors? I doubt it. Krugman, to be fair, wasn't the only so-called expert spouting off about our supposedly crumbling economy. CNN published an analysis in April with a headline that claimed "Trump took the US economy to the brink of a crisis in just 100 days." That same month, the Center for American Progress bemoaned that "President Donald Trump's decision to unilaterally launch a global trade war could be one of the worst economic statecraft blunders in American history." Opinion newsletter: Sign up for our newsletter on conservative values, family and religion from columnist Nicole Russell. Get it delivered to your inbox. I read these articles in the mainstream news media and wonder if we share the same universe. Do progressives not see the same healthy economic markers that millions of other Americans and I see? The answer, of course, is that they do see − but they are too blinded by partisanship to admit it. Good economic news should be nonpartisan I don't have a problem with liberals criticizing Trump. Sometimes he deserves it. But when it comes to obvious wins like a blossoming economy, the constant derision is tiresome and pedestrian. A robust economy under any president is good news for Americans, regardless of their party affiliation. Right? I didn't care for Biden's leftist policies. But I didn't cheer when the economy struggled. It was bad news not just for Biden but, far more important, also for our nation and its citizens. More than a year after Biden entered the White House, annual inflation spiked to 9% in June 2022, the highest rate in four decades. Americans were hit with sudden increases in food, housing and transportation costs. Opinion: Nvidia CEO says Trump gives America an advantage. Hear that, progressives? Compounding the pain, the Federal Reserve acted to cool inflation by raising interest rates, which pushed up consumers' payments for auto, housing and credit card loans. Democrats tried to blame decisions made in Trump's first term, including federal spending used to fight consequences of the COVID-19 pandemic. But Biden spent more even as the pandemic began to wane. In 2024, more than half of American voters said the economy was the issue that mattered to them the most. It's why Trump won more than 77 million votes and returned to the White House. Now, he is delivering on his promises to rebuild our nation's economy. But not everyone is happy about it. It's too bad liberals can't separate economic success from Trump's party affiliation. I can't help but wonder if they wanted a recession so they could blame Trump even more. Nicole Russell is a columnist at USA TODAY and a mother of four who lives in Texas. Contact her at nrussell@ and follow her on X, formerly Twitter: @russell_nm. Sign up for her weekly newsletter, The Right Track, here. You can read diverse opinions from our USA TODAY columnists and other writers on the Opinion front page, on X, formerly Twitter, @usatodayopinion and in our Opinion newsletter.
CNBC
2 hours ago
- CNBC
OpenAI's Sam Altman sees AI bubble forming as industry spending surges
OpenAI CEO Sam Altman thinks the artificial intelligence market is in a bubble, according to a report from The Verge published Friday. "When bubbles happen, smart people get overexcited about a kernel of truth," Altman told a small group of reporters last week. "Are we in a phase where investors as a whole are overexcited about AI? My opinion is yes. Is AI the most important thing to happen in a very long time? My opinion is also yes," he was quoted as saying. Altman appeared to compare this dynamic to the infamous dot-com bubble, a stock market crash centered on internet-based companies that led to massive investor enthusiasm during the late 1990s. Between March 2000 and October 2002, the Nasdaq lost nearly 80% of its value after many of these companies failed to generate revenue or profits. His comments add to growing concern among experts and analysts that investment in AI is moving too fast. Alibaba co-founder Joe Tsai, Bridgewater Associates' Ray Dalio and Apollo Global Management chief economist Torsten Slok have all raised similar warnings. Last month, Slok stated in a report that he believed the AI bubble of today was, in fact, bigger than the internet bubble, with the top 10 companies in the S&P 500 more overvalued than they were in the 1990s. In an email to CNBC on Monday, Ray Wang, CEO of Silicon Valley-based Constellation Research, told CNBC that he thought Altman's comments carry some validity, but that the risks are company-dependent. "From the perspective of broader investment in AI and semiconductors... I don't see it as a bubble. The fundamentals across the supply chain remain strong, and the long-term trajectory of the AI trend supports continued investment," he said. However, he added that there is an increasing amount of speculative capital chasing companies with weaker fundamentals and only perceived potential, which could create pockets of overvaluation. Many fears of an AI bubble had hit a fever pitch this year when Chinese start-up DeepSeek released its open source R1 reasoning model, claiming it had achieved its generative AI large language model for just $6 million, a fraction of the billions being spent by U.S. AI market leaders, including OpenAI. Earlier this month, Altman told CNBC that OpenAI's annual recurring revenue is on track to pass $20 billion this year, but that despite that, it remains unprofitable. The release of OpenAI's latest GPT-5 AI model earlier this month had also been rocky, with some critics complaining that it had a less intuitive feel. This resulted in the company restoring access to legacy GPT-4 models for paying customers. Following the release of the model, Altman has also signaled more caution about some of the AI industry's more bullish predictions. Speaking to CNBC, he said that he thought the term artificial general intelligence, or "AGI," is losing relevance, when asked whether the GPT-5 model moves the world any closer to achieving AGI. AGI refers to the concept of a form of artificial intelligence that can perform any intellectual task that a human can — something that OpenAI has been working towards for years and that Altman previously said could be achieved in the "reasonably close-ish future." Regardless, faith in OpenAI from investors has remained strong this year. CNBC confirmed Friday that the company was preparing to sell around $6 billion in stock as part of a secondary sale that would value it at roughly $500 billion. In March, it had announced a $40 billion funding round at a $300 billion valuation, by far the largest amount ever raised by a private tech company. In The Verge article on Friday, the OpenAI CEO also discussed OpenAI's expansion into consumer hardware, brain-computer interfaces and social media. Altman also said that he expects OpenAI to spend trillions of dollars on its data center buildout in the "not very distant future," and signaled that the company would be interested in buying Chrome if the U.S. government were to force Google to sell it. Asked if he would be CEO of OpenAI in a few years, he was quoted as saying, "I mean, maybe an AI is in three years. That's a long time."
